Fernando Aleman PhD
Fernando Aleman obtained his PharmD degree at University of Granada and his PhD at University of Murcia, both in Spain. He then performed postdoctoral studies at the University of California San Diego and the Scripps Research Institute in molecular biology, biochemistry and immunology. Dr. Aleman is the co-founder, president and Chief Scientific Officer of Navega Therapeutics. He has more than ten years of molecular biology experience and leverages his pharmaceutical, research and industry background to provide medical oversight and strategic direction for all development activities, define regulatory strategy and business development activities, and serves as the pharmaceutical point of contact for external stakeholders.